Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry

Abstract

Cell proliferation requires the coordinated activity of cytosolic and mitochondrial metabolic pathways to provide ATP and building blocks for DNA, RNA and protein synthesis. Many metabolic pathway genes are targets of the c-myc oncogene and cell-cycle regulator. However, the contribution of c-Myc to the activation of cytosolic and mitochondrial metabolic networks during cell-cycle entry is unknown. Here, we report the metabolic fates of [U-13C] glucose in serum-stimulated myc−/− and myc+/+ fibroblasts by 13C isotopomer NMR analysis. We demonstrate that endogenous c-myc increased 13C labeling of ribose sugars, purines and amino acids, indicating partitioning of glucose carbons into C1/folate and pentose phosphate pathways, and increased tricarboxylic acid cycle turnover at the expense of anaplerotic flux. Myc expression also increased global O-linked N-acetylglucosamine protein modification, and inhibition of hexosamine biosynthesis selectively reduced growth of Myc-expressing cells, suggesting its importance in Myc-induced proliferation. These data reveal a central organizing function for the Myc oncogene in the metabolism of cycling cells. The pervasive deregulation of this oncogene in human cancers may be explained by its function in directing metabolic networks required for cell proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Dang CV, O’Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F . (2006). The c-Myc target gene network. Semin Cancer Biol 16: 253–264.

    Article  CAS  Google Scholar 

  • Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE, Campisi J . (1986). Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem 261: 9161–9166.

    CAS  Google Scholar 

  • Hart GW, Housley MP, Slawson C . (2007). Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017–1022.

    Article  CAS  Google Scholar 

  • Hunt AN, Postle AD . (2004). Phosphatidylcholine biosynthesis inside the nucleus: is it involved in regulating cell proliferation? Adv Enzyme Regul 44: 173–186.

    Article  CAS  Google Scholar 

  • Jackowski S . (1994). Coordination of membrane phospholipid synthesis with the cell cycle. J Biol Chem 269: 3858–3867.

    CAS  PubMed  Google Scholar 

  • Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN . (2006). Myc influences global chromatin structure. EMBO J 25: 2723–2734.

    Article  CAS  Google Scholar 

  • Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, Evan GI . (2006). Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66: 4591–4601.

    Article  CAS  Google Scholar 

  • Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O’Donnell KA et al. (2005). Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25: 6225–6234.

    Article  CAS  Google Scholar 

  • Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B . (2003). A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100: 8164–8169.

    Article  CAS  Google Scholar 

  • Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL et al. (2007). The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both anaerobic and aerobic glycolysis. Genes Dev 21: 1037–1049.

    Article  CAS  Google Scholar 

  • Malloy CR, Sherry AD, Jeffrey FM . (1990). Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers. Am J Physiol 259: H987–H995.

    Article  CAS  Google Scholar 

  • Mandal S, Guptan P, Owusu-Ansah E, Banerjee U . (2005). Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev Cell 9: 843–854.

    Article  CAS  Google Scholar 

  • Mannava S, Grachtchouk V, Wheeler LJ, Im M, Zhuang D, Slavina EG et al. (2008). Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle 7: 2392–2400.

    Article  CAS  Google Scholar 

  • Morrish FM, Neretti N, Sedivy JM, Hockenbery DM . (2008). The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 7: 1054–1066.

    Article  CAS  Google Scholar 

  • Nikiforov MA, Chandriani S, O’Connell B, Petrenko O, Kotenko I, Beavis A et al. (2002). A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 22: 5793–5800.

    Article  CAS  Google Scholar 

  • Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M et al. (2000). Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275: 21797–21800.

    Article  CAS  Google Scholar 

  • Peet AC, McConville C, Wilson M, Levine BA, Reed M, Dyer SA et al. (2007). 1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines. NMR Biomed 20: 692–700.

    Article  CAS  Google Scholar 

  • Schorl C, Sedivy JM . (2003). Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol Biol Cell 14: 823–835.

    Article  CAS  Google Scholar 

  • Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW . (2005). Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280: 32944–32956.

    Article  CAS  Google Scholar 

  • Tollefsbol TO, Cohen HJ . (1990). The protein synthetic surge in response to mitogen triggers high glycolytic enzyme levels in human lymphocytes and occurs prior to DNA synthesis. Biochem Med Metab Biol 44: 282–291.

    Article  CAS  Google Scholar 

  • Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, Yustein JT et al. (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA 103: 17834–17839.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank John Sedivy for cell lines. This work utilized the MMC database supported by NIH grants R21 DK070297 and P41 RR02301, the MDL database (www.mdl.imb.liu.se) and the Human Metabolome database (www.hmbd.ca). A portion of this research was performed at EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research at Pacific Northwest National Laboratory. This work was funded by RO1CA106650-02 (DH). Development of the program tcaCALC (University of Texas Southwestern Medical Center) was supported by H47669-16, a Department of Veterans Affairs Merit Review Award to CR Malloy, and RR02584.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D M Hockenbery.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morrish, F., Isern, N., Sadilek, M. et al. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 28, 2485–2491 (2009). https://doi.org/10.1038/onc.2009.112

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.112

Keywords

This article is cited by

Search

Quick links